Ikervis [ciclosporin 0.1% ophthalmic emulsion] is a ciclosporin emulsion for the treatment of severe keratitis in adults with dry eye disease that has not improved with artificial tears.1 Read more
Cationorm (cationic nanoemulsion) is a new preservative-free, hydrating and lubricating emulsion which protects the eye surface, reducing the discomfort and irritation of persistent dry eye caused by prolonged use of contact lenses, or environmental conditions.1 Read more
New eye drop formulations are making dry eye treatment more affordable and accessible, especially for more severe sufferers. But Australia has often played catch up, as RHIANNON BOWMAN reports.
Pharmaceutical firm Seqirus has announced that its new therapy Ikervis is now available via the Pharmaceutical Benefits Scheme (PBS), making it Australia’s first listed disease modifying ciclosporin eye drop for severe keratitis in adults with dry eye disease (DED).
Pharmaceutical company Seqirus has announced that preservative-free dry eye therapy Cationorm is now accessible via the Pharmaceutical Benefits Scheme (PBS) in Australia. Read more
Australasian drug company AFT Pharmaceuticals has announced results from a post-market study of licensed dry eye therapy NovaTears + Omega-3, stating it is a significantly effective treatment for the evaporative form of the disease. Read more
Topcon Healthcare’s latest instrument for eye health practices wanting to strengthen their myopia and dry eye services is now available in Australia. Read more
ASX-listed AFT Pharmaceuticals has expanded its therapeutics range with a new dry eye therapy containing Omega-3. Read more
In the final instalment of Insight’s five-part dry eye series, optometrist Ms Marilyn Stern reveals how low overheads and no refraction equipment set Perth’s first dedicated dry eye clinic apart. So too does its patient demographic, with several teens counted among them. Read more
In Part 4 of Insight’s dry eye series, Melcare Biomedical CEO Anthony Moloney reveals how his company’s Australian-made product has proven to significantly reduce the severity of dry eye symptoms when compared with a conventional ocular lubricant – and hints there may be further therapies on the horizon. Read more